Capillary assisted vitrification processes and devices

ABSTRACT

Disclosed are devices and methods for non-cryogenic vitrification of biological materials that include the steps of providing one or more capillary channels of which a first opening is operably in contact with a moisture containing vitrification mixture made of a biological material and a vitrification agent. The capillary absorbs and transports the moisture to the second opening through capillary action, and the moisture is subsequently evaporated into a surrounding low humidity atmosphere until the vitrification mixture enters into a vitrified state.

CROSS REFERENCE TO RELATED APPLICATIONS

This application depends from and claims priority to U.S. ProvisionalApplication No. 62/009,562 filed Jun. 9, 2014, the entire contents ofwhich are incorporated herein by reference.

FIELD

One aspect of the present invention relates to non-cryogenicvitrification of biological materials, in particular biologicalmaterials vitrified in a vitrification medium by capillary assisted fastdrying.

BACKGROUND

Vitrification is the process of direct transition from a liquid to anamorphous glassy state and is often utilized to preserve biologicalmaterials by cooling them to cryogenic temperatures at high coolingrates. At cryogenic temperatures, vitrification technique avoids thedamaging effects of ice crystals, which are known to form duringconventional cryopreservation using slow cooling rates. However, inorder to avoid ice-nucleation during cooling, extremely high andpotentially toxic concentrations (6-8M) of cryoprotectants (CPAs) arerequired. Among the most commonly used CPAs are dimethyl sulfoxide(DMSO), glycerol, ethylene glycol (EG) and 1,2-propanediol (PROH). As aresult, multiple steps and complex elaborate protocols are required totoad and unload CPAs into cells. Therefore, alternative approaches toachieve vitrification without the need to expose biologics to highconcentrations of CPA at non-cryogenic temperature have been sought overthe years.

It is known that in order to achieve cryogenic vitrification at lowerCPA concentrations, ultra-fast heat transfer rates are required. Heattransfer rates can be increased by reducing the sample volume and/or byincreasing the cooling rate. A number of techniques have been utilizedto increase the cooling rate such as employing thin straws or ultra-thinfilms to minimize the volume to be vitrified. Patent application US2013/0157250 A1, published Jun. 20, 2013 discloses a method forcryogenic vitrification of human spermatozoa in low CPA concentrationemploying a thin straw. More recently, taking advantage of the highthermal conductivity of quartz crystal (QC) capillaries, patentapplication US 2013/0260452 A, published Oct. 3, 2013 in which N.Chakraborty is a common inventor, discloses a method for vitrificationof mammalian cells in low CPA concentration medium at ultra-rapidcooling rates.

Anhydrous vitrification at ambient temperatures may also be analternative strategy for preserving biological materials. In nature, awide variety of organisms can survive extreme dehydration whichcorrelates in many cases with the accumulation of large amounts (as muchas 20% of their dry weight) of glass forming sugars such as trehaloseand sucrose in intracellular space. Such “glass forming” sugars need tobe present on both sides of the plasma membrane to provide protectionagainst the damaging effects of desiccation. Desiccation techniquesdramatically limit or arrests the material's biochemical processes in aglassy matrix. Despite the success in vitrifying many biologicalmaterials such as proteins by anhydrous vitrification, broaderapplications to cellular materials still requires one to increase thedesiccation tolerance of the cells.

Methods to enhance desiccation tolerance include utilizing improvedvitrification medium containing trehalose, glycerol and sucrose. Whileimproved methods for loading cells with protective agents are helpful,there is a further need to develop techniques to minimize cellularinjury during desiccation. Injury and degradation may result from thehigh sensitivity of cells in general to prolonged exposure to osmoticstress during dry processing. Osmotic stress can cause cell death atrelatively high moisture content even in the presence of protectivesugars like trehalose.

The most common approach to desiccating cells involves drying in sessiledroplets with suspended cells. However, desiccation using evaporativedrying of sessile droplets is inherently slow and non-uniform in nature.A glassy skin forms at the liquid/vapor interface of the sample when thecells are desiccated in glass forming solutions. This glassy skin slowsand ultimately prevents further desiccation of the sample beyond acertain level of dryness and induces significant spatial non-uniformityof the water content across the sample. As a result, cells trapped inthe partially desiccated sample underneath the glassy skin may notvitrify but degrade due to high molecular mobility.

U.S. Pat. No. 7,883,664, in which N. Chakraborty is a common inventor,discloses a method for enhancing desiccation rate by employing microwavedrying. Further, U.S. Pat. No. 8,349,252, in which N. Chakraborty is acommon inventor, discloses a vitrified composition comprising trehalosefor vitrification by microwave drying. However, the method cannotachieve continuous drying as the biological material's temperatureincreases continuously to unsafe levels and requires a complicatedprocess control. Chakraborty et al. have also employed spin dryingtechnique to create ultra-thin films and successfully vitrified hamsterovary cells in trehalose medium. However, this approach still suffersfrom the limitations that the desiccation cannot be uniformly performedacross the entire sample surface. Further, the film has to be ultra-thinto vitrify successfully.

The development of a fast and practical desiccation technique to achievevery low and uniform final moisture levels across the sample mightovercome the shortcomings of the anhydrous vitrification techniques. Drypreservation suffers from a major limitation in long-term storage due tothe degradation of the biological material by cumulative chemicalstresses encountered as the vitrification solution gets concentrated inthe extra-cellular space. This results in irreversible cell damagebefore the cells and the vitrification solution can reach a suitably lowmoisture content to become glassy. Therefore, there exists a need forimproved vitrification medium to vitrify biological materials by fastdrying while maintaining the material's viability. A fast desiccationmethod with improved cell viability will tremendously facilitate longterm storage of biological materials at non-cryogenic temperatures aswell as overcome the challenges associated with cryogenic vitrificationand storage technologies.

SUMMARY

The following summary is provided to facilitate an understanding of someof the innovative features unique to the present invention and is notintended to be a full description. A full appreciation of the variousaspects of the invention can be gained by taking the entirespecification, claims, drawings, and abstract as a whole.

Embodiments of the present invention solve one or more problems of theprior art by providing in at least one embodiment, a method for fast anduniform moisture removal during non-cryogenic vitrification ofbiological materials,

In another embodiment, a preferred vitrification composition to preservethe structural integrity (physiological and/or molecular) of thebiological material during fast drying is provided. The saidvitrification composition comprises trehalose, glycerol and ionic buffercontaining one or more large organic ions such as choline and betine,

In yet another embodiment, a non-cryogenic vitrification device isprovided. The vitrification device comprises providing a receptacle withwalls containing a plurality of capillary channels and a requisitequantity of said biological materials and vitrification medium operablyin contact with the first openings of the capillary channels, andproviding an enclosure operably in communication with the secondopenings of the capillary channels as well as with an externalenvironment wherein the pressure, temperature and humidity within theenclosure can be controlled,

In yet another further embodiment, a vitrification and long term storageprotocol for the said vitrified biological materials is provided. Theprotocol includes placing a requisite quantity of said biologicalmaterials with vitrification medium in a receptacle comprising aplurality of said capillary channels, employing the vitrification methodof the present disclosure, packaging the said receptacle with vitrifiedbiological materials in a protective enclosure and storing the saidpackage between −196° C. to 60° C. temperatures for long term storage.

BRIEF DESCRIPTION OF THE DRAWINGS

The drawings are not necessarily to scale; some features may beexaggerated or minimized to show details of particular components.Therefore, specific structural and functional details disclosed hereinare not to be interpreted as limiting, but merely as a representativebasis for teaching one skilled in the art to variously employ thepresent invention. Exemplary aspects will become more fully understoodfrom the detailed description and the accompanying drawings, wherein:

FIG. 1 is an exemplary schematic of a sessile drop vitrification bydesiccation on an impervious substrate according to at least one knownart;

FIG. 2 is an exemplary schematic describing the mechanism of capillaryassisted drying wherein the capillary force is acting opposite togravity and the second opening is operably in communication with thedesiccating environment according to at least one embodiment of thecurrent disclosure;

FIG. 3 is an exemplary schematic describing the mechanism of capillaryassisted drying wherein the capillary force is acting in the samedirection of gravity and the second opening of the capillary channel ishydrophobic and is operably in communication with the desiccatingenvironment according to at least one embodiment of the currentdisclosure;

FIG. 4 is an exemplary schematic describing the mechanism of capillaryassisted drying wherein the capillary force is acting in the samedirection of gravity and the second opening of the capillary channel ishydrophilic and is operably in communication with the desiccatingenvironment;

FIG. 5 shows an exemplary embodiment of capillary assisted vitrificationof a sessile drop supported by a substrate comprising a plurality ofcapillary channels according to the teachings of the current disclosure;

FIG. 6A shows an exemplary embodiment of a substrate comprising aplurality of capillary channels formed by making holes into thesubstrate;

FIG. 6B shows an exemplary embodiment of a substrate comprising aplurality of capillary channels formed by weaving;

FIG. 7A shows an exemplary result of mouse oocyte desiccation performedaccording to the current teachings wherein the vitrification mediumlacks glass forming agent trehalose;

FIG. 7B shows an exemplary result of mouse oocyte desiccation performedaccording to the current teachings wherein the vitrification mixturecontains trehalose, HEPES, choline and betine;

FIG. 8A illustrates the formation ice crystals during fast drying ofultra-thin films comprising Chinese Hamster Ovary Cell in the absence ofvitrification agent trehalose;

FIG. 8B shows the complete vitrification during fast drying ofultra-thin films comprising Chinese Hamster Ovary Cell and vitrificationmedium containing Chinese Hamster Ovary Cells, 20 mM HEPES, 120 mM ChCl,1.8M Trehalose, 60 mM Betine and water;

FIG. 9 shows the glass transition temperature of a vitrified mediumcontaining Chinese Hamster Ovary Cells, 1.8 M trehalose and water;

FIG. 10 shows the glass transition temperature of a vitrified mediumcontaining Chinese Hamster Ovary Cells, 20 mM HEPES, 120 mM ChCl, 1.8MTrehalose, 60 mM Betine and water;

FIG. 11 demonstrates the efficacy of large organic ions Betine buffercompared to HEPES buffer on the viability of vitrified Chinese HamsterOvary Cell desiccated in a conventional dry box where the bright spotscorrespond to live cells (green) and the darker gray spots correspond todead (red) cells;

FIG. 12 shows an exemplary embodiment of a capillary assistedvitrification device according to the teachings of the currentdisclosure;

FIG. 13 shows another exemplary embodiment of a capillary assistedvitrification device according to the teachings of the currentdisclosure, wherein internal capillary pipes/wicks are provided withinthe vitrification mixture;

FIG. 14 shows yet another exemplary embodiment of a capillary assistedvitrification device according to the teachings of the currentdisclosure, wherein multiple cavities with inter cavity drying space andone common lid is provided;

FIG. 15 shows the cell membrane integrity retention efficacy of ChineseHamster Ovary Cells when desiccated according to the current teachingscompared to conventional dry box desiccation method, where the level ofdryness achieved by the end of the process is expressed in units ofgH₂O/gdw and 150 refers to capillary-drying betine buffer, 154 refers tobetine buffer, and 152 (open circles) refers to HEPES-trehalose buffersystem;

FIG. 16 shows the ability to achieve extremely low moisture level whileretaining cell membrane integrity of Chinese Hamster Ovary Cells whendesiccated using the methods of Example 1 illustrating the data 150 ofFIG. 15 on expanded scale where the level of dryness achieved by the endof the process is expressed in units of gH₂O/gdw; and

FIG. 17 shows the enhanced retention of insulin activity when desiccatedaccording to the vitrification method as described herein where theinsulin activity was measured by ELISA after rehydration of the sampleswhere 170 illustrates the standard, 172 illustrates the results afterdesiccation using a sample of 1 μm insulin, 100 mM trehalose, 5%glycerol and 25 min desiccation time demonstrating excellent activityrecovery, 174 illustrates 1 μm insulin after 25 min of desiccation, and176 illustrates 1 μm insulin in 100 mM trehalose, 5% glycerol and 0 mindesiccation time.

DETAILED DESCRIPTION

As required, detailed aspects of the present invention are disclosedherein; however, it is to be understood that the disclosed aspects aremerely exemplary of the invention that may be embodied in various andalternative forms.

Reference will now be made in detail to exemplary compositions, aspectsand methods of the present invention, which constitute the best modes ofpracticing the invention presently known to the inventors. The Figuresare not necessarily to scale. However, it is to be understood that thedisclosed aspects are merely exemplary of the invention that may beembodied in various and alternative forms. Therefore, specific detailsdisclosed herein are not to be interpreted as limiting, but merely as arepresentative basis for any aspect of the invention and/or as arepresentative basis for teaching one skilled in the art to variouslyemploy the present invention.

It is also to be understood that this invention is not limited to thespecific aspects and methods described herein, as specific componentsand/or conditions may, of course, vary. Furthermore, the terminologyused herein is used only for the purpose of describing particularaspects of the present invention and is not intended to be limiting inany way.

It will be understood that, although the terms “first,” “second,”“third” etc. may be used herein to describe various elements,components, regions, layers, and/or sections, these elements,components, regions, layers, and/or sections should not be limited bythese terms. These terms are only used to distinguish one element,component, region, layer, or section from another element, component,region, layer, or section. Thus, “a first element,” “component,”“region,” “layer,” or “section” discussed below could be termed a second(or other) element, component, region, layer, or section withoutdeparting from the teachings herein.

The terminology used herein is for the purpose of describing particularembodiments only and is not intended to be limiting. As used herein, thesingular forms “a,” “an,” and “the” are intended to include the pluralforms, including “at least one,” unless the content clearly indicatesotherwise. “Or” means “and/or.” As used herein, the term “and/or”includes any and all combinations of one or more of the associatedlisted items. It will be further understood that the terms “comprises”and/or “comprising,” or “includes” and/or “including” when used in thisspecification, specify the presence of stated features, regions,integers, steps, operations, elements, and/or components, but do notpreclude the presence or addition of one or more other features,regions, integers, steps, operations, elements, components, and/orgroups thereof. The term “or a combination thereof” means a combinationincluding at least one of the foregoing elements.

Unless otherwise defined, all terms (including technical and scientificterms) used herein have the same meaning as commonly understood by oneof ordinary skill in the art to which this disclosure belongs. It willbe further understood that terms such as those defined in commonly useddictionaries, should be interpreted as having a meaning that isconsistent with their meaning in the context of the relevant art and thepresent disclosure, and will not be interpreted in an idealized oroverly formal sense unless expressly so defined herein.

Throughout this application, where publications are referenced, thedisclosures of these publications in their entireties are herebyincorporated by reference into this application to more fully describethe state of the art to which this invention pertains.

The following terms or phrases used herein have the exemplary meaningslisted below in connection with at least one aspect:

“Amorphous” or “glass” refers to a non-crystalline material in whichthere is no long-range order of the positions of the atoms referring toan order parameter of 0.3 or less. Solidification of a vitreous solidoccurs at the glass transition temperature T_(g). In some aspects, thevitrification medium may be an amorphous material. In other aspects, thebiological material may be amorphous material.

“Glass transition temperature” means the temperature above whichmaterial behaves like liquid and below which material behaves in amanner similar to that of a solid phase and enters into amorphous/glassystate. This is not a fixed point in temperature, but is instead variabledependent on the timescale of the measurement used. In some aspects,glassy state may refer to the state the biological composition entersupon dropping below its glass transition temperature. In other aspects,the glassy state may refer to the state the vitrification mixture and/orvitrification agent enters upon dropping below its glass transitiontemperature. In yet other aspects, the glassy state may have themechanical rigidity of a crystal, but the random disordered arrangementof molecules characterizes a liquid.

“Crystal” means a three-dimensional atomic, ionic, or molecularstructure consisting of one specific orderly geometrical array,periodically repeated and termed lattice or unit cell.

“Crystalline” means that form of a substance that is comprised ofconstituents arranged in an ordered structure at the atomic level, asopposed to glassy or amorphous. Solidification of a crystalline solidoccurs at the crystallization temperature T_(c).

“Vitrification”, as used herein, is a process of converting a materialinto an amorphous material. The amorphous solid may be free of anycrystalline structure.

“Vitrification mixture” as used herein, means a heterogeneous mixture ofbiological materials and a vitrification medium containing vitrificationagents and optionally other materials.

“Biological material”, as used herein, refers to materials that may beisolated or derived from living organisms. Examples of biologicalmaterials include, but are not limited to, proteins, cells, tissues,organs, cell-based constructs, or combinations thereof. In some aspects,biological material may refer to mammalian cells. In other aspects,biological material may refer to human mesenchymal stem cells, murinefibroblast cells, blood platelets, bacteria, viruses, mammalian cellmembranes, liposomes, enzymes, or combinations thereof. In otheraspects, biological material may refer to reproductive cells includingsperm cells, spermatocytes, oocytes, ovum, embryos, germinal vesicles,or combinations thereof. In other aspects, biological material may referto whole blood, red blood cells, white blood cells, platelets, viruses,bacteria, algae, fungi, or combinations thereof.

“Vitrification agent”, as used herein, is a material that forms anamorphous structure, or that suppress the formation of crystals in othermaterial(s), as the mixture of the vitrification agent and othermaterial(s) cools or desiccates. The vitrification agent(s) may alsoprovide osmotic protection or otherwise enable cell survival duringdehydration. In some aspects, the vitrification agent(s) may be anywater soluble solution that yields a suitable amorphous structure forstorage of biological materials. In other aspects, the vitrificationagent may be imbibed within a cell, tissue, or organ.

“Storable or storage,” as used herein, refers to a biological material'sability to be preserved and remain viable for use at a later time.

“Above cryogenic temperature,” as used herein, refers to a temperatureabove −80° C. Room temperature, as used herein, refers to a temperaturerange between 18 and 37° C.

“Hydrophilic,” as used herein, means attracting or associatingpreferentially with water molecules. Hydrophilic materials with aspecial affinity for water, maximize contact with water and have smallercontact angles with water.

“Hydrophobic,” as used herein, means lacking affinity for water.Materials that are hydrophobic naturally repel water, causing dropletsto form, and have small contact angles with water.

“Capillary” as used herein, pertains to or occurring in or as if in atube of fine bore having a cross sectional area of 2000 μm² or less.

Vitrified materials are often prepared by rapidly cooling a liquidmaterial, or small volumes of biological materials directly immersedinto liquid nitrogen. The cooling reduces the mobility of the material'smolecules before they can pack into a more thermodynamically favorablecrystalline state. Additives that interfere with the primaryconstituent's ability to crystallize may produce amorphous/vitrifiedmaterial. In the presence of appropriate glass forming agents it ispossible to store biological materials in a vitrified matrix abovecryogenic temperatures and the vitrification can be achieved bydehydration.

Some animals and numerous plants are capable of surviving completedehydration. This ability to survive in a dry state (anhydrobiosis)depends on several complex intracellular physiochemical and geneticmechanisms. Among these mechanisms is the intracellular accumulation ofsugars (e.g., saccharides, disaccharides, oligosaccharides) that act asa protectant during desiccation, Trehalose is one example of adisaccharide naturally produced in desiccation tolerant organisms.

Sugars like trehalose may offer protection to desiccation tolerantorganisms in several different ways. A trehalose molecule mayeffectively replace a hydrogen-bounded water molecule from the surfaceof a folded protein without changing its conformational geometry andfolding due to the unique placement of the hydroxyl groups on atrehalose molecule. A sugar molecule may also prevent cytoplasmicleakage during rehydration by binding with the phospholipid heads of thelipid bilayer. Furthermore, many sugars have a high glass transitiontemperature, allowing them to form an above cryogenic temperature or aroom temperature glass at low water content. The highly viscous ‘glassy’state reduces the molecular mobility, which in turn prevents degradativebiochemical reactions that lead to deterioration of cell function anddeath.

Vitrification of biological materials by dehydration in the presence ofglass forming sugar trehalose has been disclosed N Chakraborty, et al.,Biopreservation and Biobanking, 2010, 8 (2), 107-114. With reference toFIG. 1, the system 10 is the most common approach to dehydrating abiological material. A sessile droplet 11 is placed on a substrate 12and evaporatively desiccated in an enclosure 16 having low humidityenvironment 13. The humidity, pressure and temperature inside theenclosure can be operably controlled by a control device 17. However,desiccation using evaporative drying of sessile droplets of the system10 is inherently slow and non-uniform in nature. A glassy skin 15 formsat the liquid/vapor interface 14 of the sample when the biologicalmaterials are desiccated in glass forming medium. This glassy skin 15slows and ultimately prevents further desiccation of the sample beyond acertain level of dryness and induces significant spatial non-uniformityof the water content across the sample. As a result, cells trapped inthe partially desiccated sample underneath the glassy skin may notvitrify but degrade due to high molecular mobility.

U.S. Pat. Nos. 7,883,664 and 8,349,252, in which N. Chakraboty is acommon inventor, disclosed methods for enhancing desiccation rate byemploying microwave heating. However, the method cannot achievecontinuous drying as the biological material's temperature increasescontinuously to unsafe levels and requires a complicated processcontrol. Chakraborty et al. have also employed spin drying technique tocreate ultra-thin films and enhance the desiccation rate. However, thisapproach still suffers from the limitations of the system 10, of FIG. 1,and the desiccation cannot be uniformly performed across the entiresample surface.

In view of the above-described limitations, one aspect of the presentinvention relates to a method for fast and uniform desiccation of avitrification mixture. An object of another aspect of the presentinvention is to provide a device to perform the method efficiently.Another aspect of the present invention provides a protocol for storingthe vitrified material.

With reference to FIG. 2, when a capillary 24 of uniform linear crosssectional dimension (2r, where r is ½ the cross sectional dimension) isplaced in a liquid medium or heterogeneous mixture containing liquid(e.g. porous medium) 22, the liquid level will rise in the capillary toa height h which is given by;

$\begin{matrix}{{h = {\left( \frac{2\sigma}{\rho\; g\; r} \right)\cos\;\alpha}};} & \left( {{Eqn}.\mspace{11mu} 1} \right)\end{matrix}$where, ρ is the density of the liquid, σ is the surface tension, α isthe angle of contact, g is gravity, and the pressure at evaporatingsurface P_(o)=pressure in the liquid P_(i). A negative pressure, knownas a suction potential, will exist in the liquid inside the capillary.Immediately below the meniscus 26, the suction potential will beequivalent to liquid column height h. This is the height at whichgravitational head balances the maximum capillary driving force causingcessation of flow, and could also be viewed as characteristic length fora given capillary. As the liquid evaporates, capillary meniscus 26 willdrop resulting in capillary pressure drop or head h drop. Liquid willflow into the capillary to make up for the head loss. The drying rate e₀from one (or more) capillaries with total cross-sectional area A isdependent on the flux density q flowing through the capillary can beexpressed as;e₀A=qπr²  (Eqn. 2).If the flux density q cannot keep up with the drying rate, the airenters deeper and deeper into the capillary, and reduces the capillarypressure as well as the drying rate. Further, at high evaporation ratesthrough fine capillaries, liquid flow may involve significant viscousdissipation with head loss which is proportional to flow velocity.

Thus, capillary assisted evaporation rate is affected by bothatmospheric demand (humidity, temperature and velocity of air/gas at theevaporating surface), and (i) the characteristics of the capillarychannels that generate the driving capillary force, (ii) the liquidmeniscus depth, and (iii) the viscous resistance to flow through thecapillary. Consequently, complex and highly dynamic interactions betweencapillary properties, transport processes, and boundary conditionsresult in wide range of evaporation behaviors. For fast drying the keyparameters are: (1) the conditions that support formation and sustain aliquid network at the evaporating surface and (2) the characteristicsthat promote formation of capillary pressure that induce sufficient flowto supply water at the evaporating surface. In aspect 20 of FIG. 2, thecapillary pressure gradient towards the surface is opposed bygravitational forces and viscous dissipation, whereas capillary pressuregradient is supported by smaller capillary diameter as well as smallercontact angle or hydrophilic capillary material. It is to be noted thatsmaller the capillary diameter, higher is the viscous dissipation. Toachieve optimum evaporation rate, the contact angle or wettability, thelength and the diameter of the capillary channel must be carefullybalanced.

Referring to FIG. 3, aspect 30, provides a capillary drying method wherethe drying is performed on a support including capillary channels 34.Thus, the gravitational force instead of opposing the capillary pressuregradient, becomes additive. As a result, the capillary diameter can beenlarged, reducing the viscous dissipation which controls theevaporation rate. Further, the liquid/vapor meniscus always remainsoutside the capillary preventing air entry into the capillary, thusenabling steady drying till complete desiccation. As mentioned earlier,a smaller contact angle or hydrophilic capillary material favors highercapillary head and is preferred. However, an entirely hydrophiliccapillary material is not preferred for best drying. Referring to FIG.4, in aspect 40 a hydrophilic capillary material would promote thespreading of the water on the tip 46 and would form a moisture boundarylayer reducing the evaporation rate. In contrast, a hydrophiliccapillary 34 with a hydrophobic tip 36 of aspect 30 in FIG. 3, providesimproved characteristics for drying. However, significant drying stillcan be achieved in the absence this combination and doesn't limit thescope of the present disclosure.

Referring to Equation 1, the capillary height was estimated based on theassumption that the pressures on the both sides of the interface areequal, i.e. P_(o)=P_(i). However, a reduced pressure at the evaporatinginterface i.e., P_(o)<P_(i), can further assist the capillary force andimprove the drying rate as well as drying level. This is particularlyimportant towards the end of the process when the moisture level is lowand capillary force alone cannot sustain a liquid network at theevaporating surface.

Referring to FIG. 5, illustrating favorable conditions for capillaryassisted drying, aspect 50 discloses a method for vitrification ofbiological materials, the method comprising: providing a plurality ofcapillary channels forming a capillary plate/membrane 53, the capillarychannels having a first opening 54 and a second opening 56; placing avitrification mixture 52 on the first opening 54, further exposing thesecond openings 56 and the vitrification mixture's surface 59 to asurrounding atmosphere 58 having lower humidity than the vitrificationmixture; and desiccating away the said vitrification mixture bycapillary action until the said vitrification mixture enters into aglassy state. The chemistry, humidity, pressure and temperature insidethe enclosure 55 is controlled through a control mechanism 57.

The control mechanism 57 is simplified for illustration purposes onlyand can have multiple systems and mechanisms to attain the mostfavorable conditions for desiccation and vitrification. In some aspects,a second capillary plate/membrane similar to 53 is placed directly ontop of the vitrification mixture 52 to benefit from the capillaryassisted drying method of the present disclosure at the top surface ofvitrification mixture 52. However, gravity will not favor the capillaryforce on the top. In some aspects, a flow of low humidity gas (less than30% relative humidity) is provided across the second openings 56 of thecapillary plate/membrane so as to enhance the capillary effect. Inert orrelatively inert gases such as nitrogen, argon, xenon, or others may beused as a low humidity gas. In some aspects, a reduced pressure orvacuum is maintained inside the enclosure 55. In some aspects, a suctionforce/pressure is provided across the second opening 56 to achieveincreased desiccation speed. It is to be noted that, maintaining a lowhumidity surrounding (optionally 5% relative humidity or less) isessential to prevent rehydration after desiccation has been performed.

Referring to FIG. 6A, in aspect 60, the capillary plate/membraneincludes a substrate 62 with cylindrical holes 64 forming a plurality ofcapillary channels. It must be noted that straight, substantiallyparallel, channels are shown for purposes of illustration only, thechannels actually used may be of any cross-sectional shape andconfiguration suited to the purpose, illustratively oval, circular,polygonal, irregular, or other shape. For illustration purposes, FIG. 6Bshows an aspect 65 where square cross section channels 69 are formed byweaving threads 67. The capillary drying plate/membrane is sufficientlythin and strong so as to provide low viscous dissipation yet to containthe biological materials during desiccation process.

A capillary channel has a length optionally defined by the thickness ofa substrate that forms the channels or by one or a plurality ofindividual channels themselves. A capillary channel length is optionallyone millimeter or less, but isn't limited to this specification.Optionally, a capillary channel length is between 0.1 microns to 1000microns, or any value or range therebetween. Optionally, a capillarychannel length is 5-100 microns, optionally 1-200 microns, optionally1-100 microns. A capillary channel length is optionally 5, 10, 15, 20,25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100microns. In some aspects, the length of the capillary channels variesthroughout a plurality of capillary channels, optionally in anon-uniform variation.

The cross-sectional area of the capillary channel(s) will be 2000 μm² orless. Optionally a cross-sectional area is from 0.01 μm² to 2000 μm²,optionally 100 μm² to 2000 μm², or any value or range therebetween.Optionally, a cross-sectional area of the capillary channel(s) is 100,200, 300, 400, 500, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1400,1500, 1600, 1700, 1800, 1900, or 2000 μm² or less.

Optionally, the capillary channel(s) of the invention will have a linearcross sectional dimension, optionally a diameter, of 0.1-10 microns, orany value or range therebetween. For channels that are not circular incross-section, this would correspond to a cross-sectional area of 0.01square microns to 100 square microns.

The capillary drying plate/membrane may be made of a material that isnot toxic to the biomaterials and doesn't react chemically or physicallywith the vitrification medium. This can be a suitable polymer, metal,ceramic, glass, or a combination thereof. Inert polymers or theircomposites are preferred. In some aspects, a capillary membrane isformed from polydimethylsiloxane (PDMS), polycarbonate, polyurethane,polyester (e.g. polyethylene terephthalate), among others. Illustrativeexamples of a capillary channel containing membrane suitable as asurface in the devices and processes provided herein include hydrophilicfiltration membranes such as those sold by EMD Millipore, Bellerica,Mass. A capillary drying plate/membrane is optionally formed of amaterial that is non-reactive to the biological material orvitrification agent, or other reagents/materials used in the system. Anon-reactive capillary drying plate/membrane will not substantiallybind, alter, or otherwise produce a chemical or physical associationwith a component of a vitrification medium (e.g. biological sample). Acapillary drying plate/membrane is optionally not derivitized.Optionally, capillary channels may be formed in a substrate of desiredmaterial and thickness by PDMS formation techniques, laser drilling, orother bore forming technique as is known in the art.

The presence of appropriate vitrification agents in the vitrificationmixture is critical as the mixture desiccates. The fast desiccationmethod by itself doesn't guarantee the viability of the cells or othervitrified biological material. A vitrification material/agent that formsglass, or that suppress the formation of crystals in other materials isrequired. The vitrification agent(s) may also provide osmotic protectionor otherwise enable cell survival during dehydration. Referring to FIG.7A, undesirable and harmful dendritic structures 72 that signifycrystallization as well as compromised/damaged oocyte 70 can be seen inthe sample when it was desiccated employing the method of the currentdisclosure in the absence of any glass forming vitrification agent. Thedetails of the experimental protocol is provided in the Example 2.

Illustrative examples of a vitrification agent include, but are notlimited to, dimethylsulfoxide, glycerol, sugars, polyalcohols,methylamines, betines, antifreeze proteins, synthetic anti-nucleatingagents, polyvinyl alcohol, cyclohexanetriols, cyclohexanediols,inorganic salts, organic salts, ionic liquids, or combinations thereof.A vitrification medium optionally contains 1, 2, 3, 4, or morevitrification agents.

The vitrification medium includes a vitrification agent at aconcentration that is dependent on the identity of the vitrificationagent. Optionally, the concentration of the vitrification agent is at aconcentration that is below that which will be toxic to the biologicalsample being vitrified where toxic is such that functional or biologicalviability is not achieved upon subsequent sample use. The concentrationof a vitrification agent is optionally 500 μM to 6 M, or any value orrange therebetween. For the vitrification agent trehalose, theconcentration is optionally from 1 M to 6 M. Optionally, the totalconcentration of all vitrification agents when combined is optionallyfrom 1M to 6M.

The vitrification medium optionally includes water or other solvent, abuffering agent, one or more salts or other components. A bufferingagent is any agent with a pKa of 6 to 8.5 at 25° C. Illustrativeexamples of buffering agents include HEPES, TRIS, PIPES, MOPS, amongothers. A buffering agent is provided at a concentration suitable tostabilize the pH of the vitrification medium to a desired level.

Referring to FIG. 7B, complete vitrification was achieved when mouseoocytes were desiccated employing the method of the current disclosureutilizing a vitrification mixture containing trehalose (1.8 M),glycerol, choline and betine (60 mM). The integrity of the oocyte 75 isevident and signifies the benefits of the capillary 77 assistedvitrification method disclosed herein. The importance of appropriatevitrification medium is further illustrated in FIGS. 8A and 8B. Even atthe fast desiccation rates possible in ultra-thin films (spin dryingsuch as is used on prior methods as illustrated in FIG. 1) homogeneousvitrification is not guaranteed, and FIG. 8A shows formation of icecrystals 84 in the vitrification mixture comprising Chinese hamsterovary (CHO) cells but no glass forming agent. On the contrary, the avitrification medium comprising trehalose, HEPES, ChCl, and Betineresulted in uniformly vitrified 86 biological material under ultra-thinfilms (spin drying) configuration as shown in FIG. 8B. Compared to spindrying, the capillary assisted desiccation method disclosed hereindoesn't restrict the biological material mixture to conform toultra-thin film form to achieve very fast desiccation rates of 3gH₂O/gdw/min-2 gH₂O/gdw/min.

Trehalose, a glass forming sugar, has been employed in anhydrousvitrification and may provide desiccation tolerance in several ways.Referring to FIG. 9, differential scanning calorimetry shows that avitrified 1.8M trehalose in water has a glass transition temperature 90of −15.43° C. To achieve vitrification above water freezing point 0° C.,this concentration isn't ideal and higher concentrations (6-8M) arerequired which could be damaging to the biological materials. Referringto FIG. 10, a vitrified mixture including 1.8M trehalose, 20 mM HYPES,120 mM ChCl, and 60 mM Betine shows a glass transition temperature, 100of +9° C. Further attention is drawn to the influence of the bufferingagents. As shown in FIG. 11, the use of Betine buffer that containslarge organic ions shows remarkable influence on the live/dead count 110of Chinese hamster ovary (CHO) cells after 40 minutes of desiccation ina conventional dry box compared to the use of HEPES 112, which alsocontains large organic ions. Plates 114 and 116 further emphasize thisin terms of live and dead counts after 55 minutes.

An exemplary vitrification medium for the capillary assistedvitrification method disclosed herein may include trehalose, and one ormore buffering agents containing large organic ions (>120 kDa) such ascholine or betine or HEPES as well as buffering agent(s) containingsmall ions such as K or Na or Cl. The influence of this vitrificationmedium composition on the cell membrane integrity under fast desiccationmethod of the current disclosure where ultra-low moisture levels (e.g.0.1 gH2O/gdw or less) can be instantly achieved are further illustratedin FIGS. 15 and 16 using a vitrification medium including trehalose (topreserve/stabilization large biomolecules), glycerol (topreserve/stabilize small biomolecules and prevent molecular mobility atinterstitial spaces), and choline chloride buffer. This exemplarycomposition doesn't limit the scope of using alternative formulationsfor the method disclosed herein.

The capillary assisted vitrification method may be performed at atemperature from −80° C. to +60° C. The temperature range is optionallywhere the mobility of water molecules in the sample is high and thetemperature is not detrimental to the health and viability of thebiological material. This would vary from material to material as wellas the composition of the vitrification medium. In some aspects, thevitrification temperature is 0.1° C. to 40° C. Optionally, thevitrification temperature is 4° C. to 26° C. Optionally, thevitrification temperature is 25° C.

The capillary assisted vitrification method may be performed in a dryatmosphere or environment. A dry environment is an environment with ahumidity level below saturation. In some aspects, the humidity level ofthe environment, such as the environment on the second side of thecapillary tube is 30% relative humidity or less, optionally 20% or less,optionally 10% or less, optionally 5% or less. A dry environmentoptionally has a humidity between 1% and 30% or any value or rangetherebetween, optionally between 1% and 5%.

The capillary assisted vitrification method may be performed in a lowpressure environment (less than 1 atm (760 mmHg)). A low pressureenvironment will have favorable impact on the rate or vitrification. Theenvironmental pressure is optionally 100 mmHg or 0.1 atm. Optionally,the environmental pressure is from 10 mmHg to 760 mmHg, or any value orrange therebetween. Optionally, the environmental pressure is from 10mmHg to 200 mmHg.

The capillary assisted vitrification method may be performed for adesiccation time. A desiccation time is a time sufficient to promotesuitable drying to vitrify the vitrification medium. A desiccation timeis optionally 1 second to 1 hour. Optionally, a desiccation time is 1second to 50 min, optionally 5 seconds to 60 min. Desiccation time mayvary dependent on the sample type or physical characteristics and theparticulars of the capillary channels.

The benefits of the capillary assisted vitrification method disclosedherein are further illustrated in FIG. 17. Insulin samples whenidentically desiccated in the absence of vitrification agent,significant loss in activity, 174, occurs compared to that of desiccatedin the presence of vitrification agent, 172. Further, the presence ofvitrification agent itself is not sufficient to retain the insulinactivity, 176, without desiccation. In general, significant level ofinsulin activity can be preserved following the capillary assistedvitrification method disclosed in this invention. Various proteinousmaterial can be stabilized following the capillary assistedvitrification method disclosed in this invention. It is appreciate thatthese vitrified biological materials can be sealed in protectivepackages, for transportation and long term storage. Further, some of thevitirfied biological samples can be stored in ambient temperatureswithout requiring a cold chain. They can be utilized upon rehydration.Examples include but not limited to insulin, interleukin 1, interleukin2, tetanus and hepatitis vaccines etc.

Referring to FIG. 12, aspect 120 illustrates an exemplary non-cryogenicbiological material vitrification device to exploit the benefits of thecapillary assisted vitrification method as provided herein, including: areceptacle 126 made of capillary drying plate/membrane of the currentdisclosure, having a first capillary opening inside the receptacle and asecond capillary opening outside the receptacle; a removable lid 127made of capillary drying plate/membrane of the current disclosure tofill a requisite quantity of said vitrification mixture 125 within thereceptacle wherein said vitrification mixture is operably in contactwith the first openings of the capillary channels; and an enclosure 121operably in gaseous communication with the second openings of thecapillary channels as well as with an external environment wherein thepressure, temperature and humidity within the enclosure can operably becontrolled. The outside surface of the receptacle 126 maintains a gap128 from the enclosure 121 boundary by placing perforated separators 124to facilitate gas flow and desiccation action. An enlarged view ofseparator 124 is shown at 1245.

The enclosure of aspect 120 is impervious to moisture and gas and hassealable inlet(s) 122 and outlet(s) 123. The sealable inlet(s) andoutlet(s) enable flow of gas across or maintain reduced pressure acrossthe outside surface of the receptacle in order to enhance desiccationaction. There may be a single or a plurality of inlets or outlets. Thesealing mechanism may be mechanical or adhesive based or thermalconsolidation (heat sealing). The capillary assisted vitrificationmethod can be carried out in-situ by connecting the inlet(s) andoutlet(s) to appropriate devices that can control the humidity, pressureand temperature inside the enclosure. Very fast desiccation is achieveddue to enhanced capillary contact area with the vitrification mixturefrom all sides. This also enables vitrification of larger volumes ofvitrification mixture which is a serious limitation of prior methods andsystems. In general, the thickness of the sample will be 1 centimeter orless. Optionally, the thickness will be about 1 millimeter or less. Itis understood that the thickness specification of aspect 120 is alongthe vertical axis of the picture and can be interchanged in a threedimensional construct. The method can be performed across large area.

Upon completion of the desiccation process to a desired humidity level,the inlet and outlet are sealed to prevent rehydration of the vitrifiedmaterial. Alternatively the receptacle can be utilized to desiccate thevitrification mixture in a separate chamber employing the methoddisclosed here and then sealed in the enclosure 121. The device 120 canbe configured into a wearable device optionally wherein the top lid 127and external enclosure along the seal line 122 and 123 can be removedand adhesively attached to the application surface. Many possibleconfigurations and applications are possible. Illustrative examples of awearable device can be found in U.S. Patent Application Publication No:2011/0054285 A1.

Referring to FIG. 13, further enhancement to the device is provided inanother aspect 130, wherein plurality of capillary pipes/wicks 139operably in communication with the vitrification mixture and theenclosure environment is provided in order to enhance desiccationaction. This additional feature would enable desiccation of thickervolume of vitrification mixture. A distinction between the capillarychannels of the current disclosure and capillary pipe 139 must be made.Capillary device 139 can be a hollow cylinder comprising thecharacteristics of the receptacle 136 as shown in 1395. As such, a pipecan be envisioned as a substantially tubular substrate of capillarychannels that extends into the sample so as to effectively increase thesurface area of the environment external to the sample. The end of thepipe in contact with the vitrification mixture is optionally closed.Alternatively, a wick comprising capillary channels can be alsoutilized, however, a pipe is preferred. Most of the discussionspertaining to aspect 120 are also applicable to aspect 130 and arerepeated.

Referring to FIG. 14, an additional aspect 140 is provided including areceptacle formed of multiple cavities 144 with inter cavity dryingspace and one common lid 142 in order to enhance desiccation action.Alternatively, each cavity can also have individual lids. Specification141 and 145 constitute the external enclosure and 143 is thevitrification mixture including the sample. Although the inlets andoutlets of the device are not shown in the picture, the device operatesaccording to the teachings of the current disclosure and discussionspertaining to aspect 120 and 130 are applicable to this aspect. Further,the capillary pipes/wicks of aspect 130 can also be deployed in thisaspect. The devices in aspects 120, 130, and 140, are sufficientlyflexible and reconfigurable to become a wearable device.

The duration a biological material may remain viable in vitrified stateduring storage above cryogenic temperature may vary from one samplematerial to the next. In some aspects, a biological material may remainviable while in storage above cryogenic temperature for 2-20 days. Inother aspects, a biological material may remain viable while in storageabove cryogenic temperature for 10 weeks. In other aspects, a biologicalmaterial may remain viable in storage above cryogenic temperature for upto one year. In other aspects, a biological material may remain viablewhile in storage above cryogenic temperature for up to 10 years.

Alternatively, after vitrification above cryogenic temperaturesemploying the teachings and devices of the current disclosure, thevitrified biological material can be stored at cryogenic temperaturesfor very long periods. For many biological materials, this is apreferred approach to avoid cryoinjury that commonly occurs duringdirect vitrification at cryogenic temperatures. A preferred approach inone aspect is to vitrify the biological materials at room temperaturesutilizing low concentrations of vitrification agents (e.g. <2Mtrehalose) and then immediately store at cryogenic temperatures.Therefore, the said device is optionally made out of materials storableat a temperature between −196° C. to 60° C. following the vitrificationaccording to the teachings of the current disclosure.

Further benefits of the disclosed method and devices rare illustrated inFIGS. 15 and 16. Referring to FIG. 15, the cell membrane integrity ofdesiccated Chinese hamster ovary (CHO) cells is compared at differentmoisture levels. Open circles 152 represent the membrane integrity vsmoisture level while desiccating a vitrification mixture comprising 1.8Mtrehalose with HEPES buffer in a conventional dry box. As can be seenthe cell membrane is completely destroyed by the time the moisture levelreached 1 gH₂O/gdw. When Betine buffer was utilized in dry boxdesiccation process the membrane integrity represented by closed circles154 improved compared HEPES buffer, however the membranes were almostdestroyed when the moisture reached 1 gH₂O/gdw level. The benefits ofcapillary assisted fast desiccation method disclosed herein isillustrated by the closed circles 150 demonstrating that the membraneintegrity is largely preserved even when the moisture level has reachedextremely low level that is not feasible in conventional dry boxdesiccation processes. The moisture levels that are achievable by thedisclosed method is further illustrated in FIG. 16. While Betine bufferhelps in the preservation of the membrane integrity, the fastdesiccation process of the current disclosure vitrifies the biologicalmaterials before even they realize which is largely responsible for theretention their integrity.

EXAMPLES 1. Experiments with Chinese Hamster Ovary (CHO) Cells

Cell Culture: Chinese hamster ovary (CHO) cells were obtained fromAmerican Type Culture Collection (ATCC, Manassas, Va.), and cultured inDulbecco' modified Eagle's medium (DMEM) (Invitrogen, Carlsbad, Calif.)supplemented with 10% fetal bovine serum (Atlanta Biologicals, Norcross,Ga.) and 2% penicillin-streptomycin (10 U/mL penicillin G and 10 μg/mLstreptomycin sulfate, Invitrogen, Carlsbad, Calif.). Cultures weremaintained in 25-cm² T-flasks (Corning Incorporated, NY) at 37° C. andequilibrated with 10% CO₂-90% air. Following cell culture to desiredconfluency of 70%, the cells were trypsinized, pelleted and re-dispersedto create a concentration of 1×10⁵ cells/mL in DMEM.

Device Assembly: A PDMS cast was created having a dimension of 0.25inch×0.38 inch having a central circular cavity (0.05 inch) and apolypropylene membrane (obtained from Sterlitech Corporation, Kent,Wash.) having pore sizes of 5 μm and thickness of 100 μm was placed onit. These pores provided the desired capillary action to desiccate thecells. This assembly was utilized as the capillary device. The entireset-up was housed inside a custom-built enclosure (polystyrene, 6×8×6inches) containing a low moisture atmosphere (˜2% RH) and was purgedwith medical grade nitrogen to prevent moisture pickup through the opensurface of the sample. A lid attached to a computer-controlledmicro-pump (Dolomite, Charlestown, Mass.) was placed on the cavity tofacilitate fast removal of moisture from the samples through thecapillary channels.

Desiccation: After placing a 20 μL sample of cells suspended at aconcentration of 1×10⁵ cells/mL on top of the capillary substrate, themicro pump was initiated (1 mL/min) to desiccate the sample. Thedesiccation of the biological sample took place within 5 secs.Desiccation experiments were conducted with cell samples without glassforming agents such as trehalose as well as with a vitrification mediumcomprising HEPES: 20 mM, ChCl: 120 mM, Trehalose: 1.8M, Beane: 60 mM,and the pH adjusted with potassium salts to 7.2 (SAMADHI), Comparativeexperiments were also conducted on quartz substrates without employingthe capillary device in a conventional dry box containing low moistureand was purged with medical grade nitrogen. Following desiccation, thecell samples were removed and membrane integrity was evaluated.

Quantification of Residual Moisture: Bulk gravimetric analysis of thewater content of the samples was performed using a high precisionanalytical balance (Metler Toledo XP Ultra Microbalance, Columbus,Ohio). The initial and final sample weights were measured and used tocalculate moisture content. Dry weights of samples were determined bybaking in a vacuum oven at a temperature below the glass transitiontemperature of trehalose (˜90° C.) for 8 h.

Viability Assessment: The membrane integrity was determined usingSyto-13/ethydium bromide membrane integrity assays (Molecular Probes,Eugene, Oreg.). The stock solution for the Syto-13/ethydium bromidestaining was prepared by adding 10 μL of 1 mg/mL Syto -13 solution (aq.)and 5 μL of 1.0 mg/mL solution ethydium bromide solution (aq.) to 8 mLof DMEM without phenol red or serum (Invitrogen Inc., Carlsbad, Calif.).After rehydration, 500 μL of Syto-13/ethydium bromide solution wereadded to the cells attached on coverslips, and the samples wereincubated at 37° C. for 5 min. These samples were then imaged using aninverted microscope (Carl Zeiss Biosystems, Oberkochen, Germany) usingFITC and PI filters. Cell viability was determined immediately afterrehydration with this technique by counting the live (green) and dead(red) cells in seven representative images taken at different locationson the coverslip. Illustrative results are presented in FIG. 11.

2. Experiments with Mouse Oocyte:

Animals: Six-week-old B6D2F1 female mice were purchased from CharlesRiver Laboratories (Boston, Mass., USA). All animal experiments werecarried out with the approval of the animal care and use committee.

Retrieval of oocytes: The 6-week-old B6D2F1 female mice weresuperovulated with 7.5 IU of pregnant mare serum gonadotrophin(Sigma-Aldrich, St. Louis, Mo., USA) and 7.5 IU of human chorionicgonadotrophin (Sigma-Aldrich) given by intraperitoneal injections 48 hapart. Fourteen hours after human chorionic gonadotrophin injection,females were anaesthetized with avertin (Sigma-Aldrich) then killed bycervical dislocation and their oviducts were removed. Thecumulus-oocyte-complex was released from the ampullary region of eachoviduct by puncturing the oviduct with a 27-gauge needle. Cumulus cellswere removed by exposure to hyaluronidase (80 IU/ml) (Irvine Scientific,Santa Ana, Calif., USA) for 3 min and washed three times with humantubal fluid (HTF) medium (Irvine Scientific) with 10% fetal bovine serum(FBS; Gibco, Carlsbad, Calif., USA). Oocytes were transferred andcultured in HTF medium (Quinn et al. 1995) containing 10% FBS at 37° C.and 5% CO₂ in air until they were vitrified by desiccation.

Desiccation: Desiccation experiments were performed employing thecapillary device described in Example 1 above and following the sameprotocols.

3. Experiments with Insulin:

Materials and Methods: Chemically defined, recombinant fromSaccharomyces cerevisiae human insulin solution with a concentration of10 mg/mL was obtained from Sigma-Aldrich (St. Louis, Mo.) and stored at4° C. High purity, low endotoxin trehalose dihydrate was obtained fromPfanstiehl (Cleveland, Ohio) and glyercol was acquired fromSigma-Aldrich. The insulin was serially diluted down to produce a stocksolution of 25 μg/mL insulin concentration in UltraPure™ distilled waterand the solution was added to the previously vortexed trehalose-basedsolution. A separate insulin-based distilled water solution with notrehalose or glycerol was designated as the control group. Bothexperimental and control solutions were stored at 4° C. EMD Millipore(Billerica, Mass.) hydrophilic membrane with 0.22 μm pore size was usedas the capillary substrate. All samples were placed within a vacuumchamber which was connected to an Edwards RV3 Two Stage Rotary Vane Pump(Crawley, United Kingdom) and Drierite desiccation column. Theinsulin-based samples were then continuously dried under vacuum for aduration of 25 minutes at a pressure between −27 and −30 in Hg. Afterdrying, samples were removed and reweighed to determine the amount ofwater loss due to drying. The Moisture Residue Ratio (gH₂O/gdw) wascalculated for all desiccated samples to quantify the efficiency of thedesiccation procedure. After desiccation, all samples were rehydrated in4× the amount of distilled water lost due as a result of drying.Concurrently, “undesiccated” samples of the trehalose-based insulinsolution were rehydrated in distilled water to serve as a proteiniousactivity benchmark for the desiccated samples. The ELISA protocolprovided by the supplier (Life Technologies) was followed after whichthe microtiter plate containing standards and all groups of samples wereread and analyzed by the Epoch 2 Microplate Spectrometer (BioTekInstruments, Winooski, Vt.) with related Gen5 Data Analysis softwarethat generates optical density (OD) readings signifying proteinactivity. Results are illustrated in FIG. 17.

While aspects of the invention have been illustrated and described, itis not intended that these aspects illustrate and describe all possibleforms of the invention. Rather, the words used in the specification arewords of description rather than limitation, and it is understood thatvarious modifications and substitutions may be made thereto withoutdeparting from the spirit and scope of the invention.

PATENT DOCUMENT REFERENCES 6,808,651 B1 October 2004 Katagiri, et al.7,883,664 B2 February 2011 G. Elliott; N. Chakraborty. 8,349,252 B2January 2013 G. Elliott; N. Chakraborty. US 2013/0157250 A1 June 2013Gutierrez et al. US 2013/0260452 A1 October 2013 Toner et al.

NON-PATENT REFERENCES

Chakraborty N, Menze M A, Malsam J, Aksan A, Hand S C, et al. (2011)Cryopreservation of Spin-Dried Mammalian Cells, PLoS ONE 6(9): e24916.

Chakraborty N, Biswas D, Elliott G D (2010) A Simple Mechanistic Way toIncrease the Survival of Mammalian Cells During Processing for DryStorage, Biopreservation and Biobanking, 8 (2), 107-114.

Various modifications of the present invention, in addition to thoseshown and described herein, will be apparent to those skilled in the artof the above description. Such modifications are also intended to fallwithin the scope of the appended claims.

It is appreciated that all reagents are obtainable by sources known inthe art unless otherwise specified.

Patents, publications, and applications mentioned in the specificationare indicative of the levels of those skilled in the art to which theinvention pertains. These patents, publications, and applications areincorporated herein by reference to the same extent as if eachindividual patent, publication, or application was specifically andindividually incorporated herein by reference.

The foregoing description is illustrative of particular embodiments ofthe invention, but is not meant to be a limitation upon the practicethereof. The following claims, including all equivalents thereof, areintended to define the scope of the invention.

The invention claimed is:
 1. A non-cryogenic biological materialvitrification device comprising: a) a receptacle comprising a firstmembrane and a second membrane, the first membrane, the second membrane,or both comprising a plurality of contiguous capillary channels eachhaving a first opening and a second opening, the first membrane and saidsecond membrane arranged so as to be able to contact a vitrificationmixture when placed in the receptacle such that the first membranecontacts a first surface of the vitrification mixture and the secondmembrane contacts a second surface of the vitrification mixture suchthat the first opening of said capillary channels is operably in contactwith said vitrification mixture; and b) an enclosure operably in fluidiccommunication with said second openings of the capillary channels toform an enclosure environment, said enclosure in fluidic communicationwith an external environment wherein a pressure, temperature, humidity,or combinations thereof within said enclosure environment can operablybe controlled.
 2. The device of claim 1, wherein an outside surface ofsaid enclosure comprises one or more sealable inlets and one or moresealable outlets to facilitate gas flow and desiccation action.
 3. Thedevice according to claim 2, the sealable inlet(s) and outlet(s) enableflow of gas across or maintain reduced pressure across said secondopenings in order to enhance desiccation action.
 4. The device accordingto claim 1, wherein said enclosure is impervious to moisture and gas. 5.The device of claim 1, further comprising one or more capillary pipes orcapillary wicks operably in communication with said vitrificationmixture and an enclosure environment in order to enhance desiccationaction.
 6. The device of claim 1, wherein said receptacle comprisesmultiple cavities comprising an inter cavity drying space.
 7. The deviceof claim 1, wherein said device is configured as a wearable device. 8.The device according to claim 1, wherein said enclosure and saidreceptacle comprise material storable at a temperature between −196° C.to 60° C.
 9. The device according to claim 1 wherein the first openingof said capillary channels in said first membrane are proximal and thefirst opening of said capillary channels in said second membrane, andthe second opening of said capillary channels in said first membrane areopposite and the second opening of said capillary channels in saidsecond membrane.